Cargando…
Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis
Lactate blunts the anticancer immune response in breast cancer (BC). However, little is known about the exact effect of lactate transporters such as monocarboxylate transporter 4 (MCT4) on immunotherapy. In this study, we investigated the expression status and prognostic value of MCT4 in BC through...
Autores principales: | Yuan, Chen, Zhang, Jie, Lou, Jianjuan, Wang, Siqi, Jiang, Yanni, Wu, Feiyun, Wang, Shouju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806482/ https://www.ncbi.nlm.nih.gov/pubmed/34269158 http://dx.doi.org/10.1080/21655979.2021.1951928 |
Ejemplares similares
-
Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019) -
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011) -
High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer
por: Tong, Ying-Hui, et al.
Publicado: (2021) -
Inhibition of monocarboxylate transporters (MCT) 1 and 4 reduces exercise capacity in mice
por: Kitaoka, Yu, et al.
Publicado: (2022) -
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)